Stifel analyst Paul Matteis raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Neurocrine Bio. (NBIX) PT Raised to $145 at Piper Sandler Due to Ingrezza Long-Term PotentialAugust 4, 2020 9:10 AM